The effects of 13-cis retinoic acid and interferon-α in chronic myelogenous leukemia cells in vivo in patients

被引：12

作者：

Handa, H ^{[1
]}

Hegde, UP ^{[1
]}

Kotelnikov, VM ^{[1
]}

Mundle, SD ^{[1
]}

Dong, LM ^{[1
]}

Burke, P ^{[1
]}

Rose, S ^{[1
]}

Hsu, WT ^{[1
]}

Gaskin, F ^{[1
]}

Raza, A ^{[1
]}

Preisler, HD ^{[1
]}

机构：

[1] Rush Presbyterian St Lukes Med Ctr, Rush Canc Inst, Chicago, IL 60612 USA

来源：

LEUKEMIA RESEARCH | 1997年 / 21卷 / 11-12期

关键词：

retinoic acid; interferon; CML;

D O I：

10.1016/S0145-2126(97)00090-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The effects of the administration of a 3-day course of 13-cis retinoic acid in combination with interferon a [RA/IFN] on the leukemia cells was measured in vivo in 43 patients with chronic myelogenous leukemia. The administration of RA/IFN was associated with a significant fall in the white blood cell count of patients with chronic-phase disease and with a fall in the percentage S-phase cells in CML patients regardless of the stage of their leukemia. In two thirds of the patients studied the administration of RA/IFN was also associated with an increase in marrow apoptosis. The cytokine combination also suppressed bcl-2 and myc expression in a minority of patients and such expression appears to be associated with response to a treatment regimen which includes RA/IFN. These studies are the first to directly assess the effects of the combination of RA/IFN on chronic myelogenous leukemia cells in vivo in patients. These effects, if seen in other malignant diseases, could account for the therapeutic benefit which has been associated with the administration of this combination of biological agents to patients with malignant disease. (C) 1997 Elsevier Science Ltd. All rights reserved.

引用

页码：1087 / 1096

页数：10

共 17 条

[11]

MUNDLE S, 1994, LEUKEMIA RES, V18, P149

[12]

PREISLER HD, 1992, CANCER RES, V52, P4090

[13] PROLIFERATIVE ADVANTAGE RATHER THAN CLASSICAL DRUG-RESISTANCE AS THE CAUSE OF TREATMENT FAILURE IN CHRONIC MYELOGENOUS LEUKEMIA [J].

PREISLER, HD ;

RAZA, A ;

BACCARANI, M .

LEUKEMIA & LYMPHOMA, 1993, 11 :303-306

[14]

PREISLER HD, 1992, BLOOD, V80, P2600

[15]

RAZA A, 1987, BLOOD, V69, P1647

[16] ANTIPROLIFERATIVE AND SYNERGISTIC EFFECT OF INTERFERON ALPHA-2A, RETINOIDS AND THEIR ASSOCIATION IN ESTABLISHED HUMAN CANCER CELL-LINES [J].

TOMA, S ;

MONTEGHIRFO, S ;

TASSO, P ;

NICOLO, G ;

SPADINI, N ;

PALUMBO, R ;

MOLINA, F .

CANCER LETTERS, 1994, 82 (02) :209-216

[17]

TURA S, 1975, SER HAEMATOL, V8, P121

← 1 2 →